New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases

A Shehzad, T Ha, F Subhan, YS Lee - European journal of nutrition, 2011 - Springer
Purpose A metabolic abnormality such as obesity is a major obstacle in the maintenance of
the human health system and causes various chronic diseases including type 2 diabetes …

[HTML][HTML] Therapeutic applications of curcumin nanomedicine formulations in cardiovascular diseases

B Salehi, ML Del Prado-Audelo, H Cortés… - Journal of clinical …, 2020 - mdpi.com
Cardiovascular diseases (CVD) compromises a group of heart and blood vessels disorders
with high impact on human health and wellbeing. Curcumin (CUR) have demonstrated …

[HTML][HTML] The effects of nano-curcumin supplementation on risk factors for cardiovascular disease: a GRADE-assessed systematic review and meta-analysis of clinical …

D Ashtary-Larky, M Rezaei Kelishadi, R Bagheri… - Antioxidants, 2021 - mdpi.com
Previous studies have indicated that curcumin supplementation may be beneficial for
cardiometabolic health; however, current evidence regarding the effects of its nanorange …

Curcumin treatment protects against renal ischemia and reperfusion injury–induced cardiac dysfunction and myocardial injury

TH Chen, YC Yang, JC Wang, JJ Wang - Transplantation proceedings, 2013 - Elsevier
Objectives Renal ischemia and reperfusion (I/R) injury frequently leads to acute renal failure
(ARF) and multiple-organ injury with a substantial morbidity rate. The primary cause of ARF …

Three months of combination therapy with nano‐curcumin reduces the inflammation and lipoprotein (a) in type 2 diabetic patients with mild to moderate coronary …

M Dastani, HR Rahimi, VR Askari, MR Jaafari… - Biofactors, 2023 - Wiley Online Library
Diabetes is one of the most common chronic diseases worldwide. Systemic inflammation
(high‐sensitivity C‐reactive protein (hs‐CRP)) and lipid metabolism disruption (lipoprotein …

The targets of curcumin

H Zhou, CS Beevers, S Huang - Current drug targets, 2011 - ingentaconnect.com
Curcumin (diferuloylmethane), an orange-yellow component of turmeric or curry powder, is a
polyphenol natural product isolated from the rhizome of the plant Curcuma longa. For …

[HTML][HTML] Pharmacological mechanisms and clinical applications of curcumin: update

M Hao, Y Chu, J Lei, Z Yao, P Wang, Z Chen… - Aging and …, 2023 - ncbi.nlm.nih.gov
Curcumin, a well-known hydrophobic polyphenol extracted from the rhizomes of turmeric
(Curcuma longa L.), has attracted great interest in the last ten years due to its multiple …

The potential effect of garlic extract and curcumin nanoparticles against complication accompanied with experimentally induced diabetes in rats

AD Abdel-Mageid, MES Abou-Salem, NMHA Salaam… - Phytomedicine, 2018 - Elsevier
Background Modified herbal medicines implicate the combination of several therapeutic
practices of native systems of medicine that may extend many earlier generations, which …

[HTML][HTML] Curcumin supplementation and human disease: a scoping review of clinical trials

TM Panknin, CL Howe, M Hauer… - International Journal of …, 2023 - mdpi.com
Medicinal properties of turmeric (Curcuma longa L.), a plant used for centuries as an anti-
inflammatory, are attributed to its polyphenolic curcuminoids, where curcumin predominates …

[HTML][HTML] Biomedical applications and bioavailability of curcumin—An updated overview

SI Sohn, A Priya, B Balasubramaniam… - Pharmaceutics, 2021 - mdpi.com
Curcumin, a yellow-colored molecule derived from the rhizome of Curcuma longa, has been
identified as the bioactive compound responsible for numerous pharmacological activities of …